Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

NXbio Development AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 2,713 Less Arrow 1,889 More Arrow 3,256
Earnings before taxes -45,856 More Arrow -19,543 Less Arrow -29,199
EBITDA -142 Less Arrow -166 More Arrow -43
Total assets 128,923 More Arrow 203,258 Less Arrow 165,589
Current assets 128,823 More Arrow 203,158 Less Arrow 165,489
Current liabilities 129 Less Arrow 61 Less Arrow 37
Equity capital 81,345 More Arrow 126,862 More Arrow 146,405
- share capital 3,775 Equal arrow 3,775 Equal arrow 3,775
Employees (average) 2 Equal arrow 2 Equal arrow 2

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 63.1% Less Arrow 62.4% More Arrow 88.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -33.5% More Arrow -8.7% Less Arrow -15.7%
Current ratio 99862.8% More Arrow 333045.9% More Arrow 447267.6%
Return on equity (ROE) -56.4% More Arrow -15.4% Less Arrow -19.9%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Equal arrow 0 More Arrow 2
Chg. No. of employees % 0% Equal arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.